TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CellSource Co., Ltd. ( (JP:4880) ) has issued an announcement.
CellSource Co., Ltd. reported its September 2025 KPI results for contract processing services, noting a stable daily average number of orders at 51.2. The company saw a significant shift in order distribution, with a decrease in self-funded orthopedics orders and an increase in hybrid orthopedics. Efforts are being made to address the decline in self-funded orders through strategic reviews and support services, while initiatives for hybrid orthopedics continue to target key medical institutions.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen742.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
Average Trading Volume: 71,854
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen11.42B
See more insights into 4880 stock on TipRanks’ Stock Analysis page.